Stenotrophomonas maltophilia Infections in Pediatric Patients – Experience at a European Center for Pediatric Hematology and Oncology
Open Access
- 12 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Stenotrophomonas maltophiliais an important nosocomial pathogen in immunocom-promised individuals and characterized by intrinsic resistance to broad-spectrum antibacterial agents. Limited data exists on its clinical relevance in immunocompromised pediatric patients, particularly those with hematological or oncological disorders. In a retrospective single center cohort study in pediatric patients receiving care at a large european pediatric hematology and oncology department, ten cases of invasiveS.maltophiliainfections (blood stream infections (BSI), 4; BSI and pneumonia, 3, or soft tissue infection, 2; and pneumonia, 1) were identified between 2010 and 2020. Seven patients had lymphoblastic leukemia and/or were post allogeneic hematopoietic cell transplantation. InvasiveS.maltophiliainfections occurred in a setting of indwelling central venous catheters, granulocytopenia, defective mucocutaneous barriers, treatment with broad-spectrum antibacterial agents, and admission to the intensive care unit. Whole genome sequencing based typing revealed no genetic relationship among four individualS.maltophiliaisolates. The case fatality rate and mortality at 100 days post diagnosis were 40 and 50%, respectively, and three patients died from pulmonary hemorrhage. InvasiveS.maltophiliainfections are an emerging cause of infectious morbidity in patients receiving care at departments of pediatric hematology and oncology and carry a high case fatality rate.Keywords
This publication has 61 references indexed in Scilit:
- Stenotrophomonas maltophilia – The most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: A prospective multicenter studyJournal of Infection, 2012
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic PathogenClinical Microbiology Reviews, 2012
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with CancerClinical Infectious Diseases, 2007
- Bloodstream Infection Caused by Stenotrophomonas maltophilia in ChildrenThe Pediatric Infectious Disease Journal, 2007
- Global Emergence of Trimethoprim/Sulfamethoxazole Resistance inStenotrophomonas maltophiliaMediated by Acquisition ofsulGenesEmerging Infectious Diseases, 2007
- Antimicrobial therapy for Stenotrophomonas maltophilia infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Activities of Ciprofloxacin and Moxifloxacin against Stenotrophomonas maltophilia and Emergence of Resistant Mutants in an In Vitro Pharmacokinetic-Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2004
- Septicaemia due to glucose non‐fermenting, Gram‐negative bacilli other than Pseudomonas aeruginosa in childrenActa Paediatrica, 2002
- Bacteremia Due to Stenotrophomonas maltophilia in Patients with Hematologic MalignanciesClinical Infectious Diseases, 2000